Last updated: March 26, 2024
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Female Hormonal Deficiencies/abnormalities
Treatment
Magnetic Resonance Ductography (MRD); and High-Resolution Magnetic Resonance Ductography (HR-MRD)
Clinical Study ID
NCT05812040
SYSKY-2023-122-02
Ages 18-75 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Female patients aged between 18 and 75 years old.
- Pathological nipple discharge patients who received treatment at Sun Yat-sen MemorialHospital. The diagnostic criteria for pathological nipple discharge includeunilateral, single duct orifice, and spontaneous discharge of serous or bloody fluid.Patients who meet any of the above criteria are considered as pathological discharge.
- Willing to sign an informed consent form for clinical research and undergo HR-MRD andMRD examination.
Exclusion
Exclusion Criteria:
- Patients who have undergone surgery on the nipple-areolar complex of the PND breastside within the past year.
- Patients who have claustrophobia or metal implants in their body, which are notsuitable for MRI scans.
- Patients who are pregnant or breastfeeding.
Study Design
Total Participants: 88
Treatment Group(s): 1
Primary Treatment: Magnetic Resonance Ductography (MRD); and High-Resolution Magnetic Resonance Ductography (HR-MRD)
Phase:
Study Start date:
March 02, 2023
Estimated Completion Date:
May 30, 2024
Connect with a study center
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, Guangdong 510120
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.